Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Rodan Launch date musings
View:
Post by wexworth on Feb 02, 2021 12:43pm

Rodan Launch date musings

Clinical study demonstrated two primary advantages of 1067 for the treatment of dyschromia (uneven skin tone/dark spots).

1. unlike hydroquinone containing products, Sirona's 1067 has the very specific clinical study proven advantage of targeting the dychromia and not the broader skin tone unique to the individual.

2. that Sirona's 1067 forumla is safe and cancer free

These are both game changers.

A couple of things that I am wondering about:

1. 2020 brought two big changes for the skin lightening market and reaffirmed for the world what is considered acceptable, socially and for human safety. What is the cosmetics industry response to both the BLM movement and widespread regulatory clamp down?

So far, many major cosmetics firms have pulled their hydronquinone containing products not just for safety and regulatory compliance but also in response to their obligation to do what is right.

There is a distinct difference between lightening your entire skin and just treating an annoying dark spot/aging spot. One is more and more seen as socially intolerant, the other is perfectly legitimate. Furthermore, Hydroquinone is akin to trying to surgically remove a problematic area with a hatchet, while Sirona's 1067 treatment would be akin to laser precision. 

If you want a legitimate treatment for a problematic area, you now require a doctors prescription for hydroquinone to treat dyschromia and you have to make sure you don't go "over the line" and inadvertently lighten the surrounding skin area. Nice, I replace my dark spot with a light and dark mess. And I get cancer. No thank you.

2. If one was going to go out with a leading position with this brand new product line, when would be the right time of the year which would resonate the best for brand awareness and a social campaign?

I am hoping this month or next, and it may be brilliant if it ends up being this month and the message is properly structured, but again, please caution as we have been completely off base two times before.

It has to come out some time, so the question is when?
Comment by pointer on Feb 02, 2021 1:30pm
This post has been removed in accordance with Community Policy
Comment by wexworth on Feb 02, 2021 1:35pm
well, if you wish, I can certainly get the exact quote here. I will have a look and post here. perhaps the 0.4% is the product for china, and maybe that will have a differing effect. dyschromia is the game here in north america, not bleaching skin.
Comment by wexworth on Feb 02, 2021 1:44pm
Please debate me here pointer - but from what I read, and I have validated this as well, the product has a highly desireable and unique advantage.... The market is massive any way you cut it, so yeah, don't worry about missing out on the big market $$$$$. https://onlinelibrary.wiley.com/doi/10.1111/jocd.13771 Clinical results: "TFC1067 and 2% hydroquinone produced statistically ...more  
Comment by pointer on Feb 02, 2021 2:00pm
This post has been removed in accordance with Community Policy
Comment by wexworth on Feb 02, 2021 2:33pm
you are basically leading one to conclude that the 0.4% could produce a meaningful effect of lightening normal skin as you suggest. this is not what it looks like the rodan purpose is for.
Comment by pointer on Feb 02, 2021 3:13pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities